A composite measure of personal financial burden among patients with stage III colorectal cancer

Medical Care

Volumn 52, Issue 11, 2014, Pages 957-962

  Veenstra, Christine M ^a   Regenbogen, Scott E ^a   Hawley, Sarah T ^b   Griggs, Jennifer J ^a   Banerjee, Mousumi ^c   Kato, Ikuko ^d   Ward, Kevin C ^e   Morris, Arden M ^a  

^a Center for Healthcare Outcomes and Policy   (United States)

^b Division of General Medicine Cancer Surveillance and Outcomes Research Team   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

Chemotherapy; Colorectal cancer; Factor analysis; Finances; Financial burden

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; COST OF ILLNESS; EMPLOYMENT STATUS; FEMALE; FINANCIAL DEFICIT; HEALTH CARE NEED; HEALTH INSURANCE; HEALTH STATUS; HEALTH SURVEY; HUMAN; LIKERT SCALE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PERSONAL FINANCIAL BURDEN; QUALITY OF LIFE; SCORING SYSTEM; SELF CONCEPT; SOCIAL STATUS; SOCIOECONOMICS; COLORECTAL NEOPLASMS; DRUG COST; ECONOMICS; EPIDEMIOLOGY; FACTORIAL ANALYSIS; FINANCIAL MANAGEMENT; GEORGIA; INFORMATION PROCESSING; PATHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COST OF ILLNESS; DATA COLLECTION; DRUG COSTS; FACTOR ANALYSIS, STATISTICAL; FEMALE; FINANCING, PERSONAL; GEORGIA; HUMANS; MALE; MICHIGAN; MIDDLE AGED; NEOPLASM STAGING; SOCIOECONOMIC FACTORS;

EID: 84916595305     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000241     Document Type: Article

References (24)

1. SEER Cancer Statistics Factsheets: Colon and Rectum Cancer. National Cancer Institute; Bethesda, MD. Available at: http://seer.cancer.gov/statfacts/html/colorect.html. Accessed May 2, 2014.
2. Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27: 3109-3116.
3. Shankaran V, Jolly S, Blough D, et al. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30: 1608-1614.
4. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18:381-390.
5. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol. 2007;25:180-186.
6. Langa KM, Fendrick AM, Chernew ME, et al. Out-of-pocket healthcare expenditures among older Americans with cancer. Value Health. 2004;7:186-194.
7. Arozullah AM, Calhoun EA, Wolf M, et al. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004;2:271-278.
8. Banegas MP, Yabroff KR. Out of pocket, out of sight? An unmeasured component of the burden of cancer. J Natl Cancer Inst. 2013;105: 252-253.
9. Ramsey S, Blough D, Kirchhoff A, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013;32:1143-1152.
10. Markman M, Luce R. Impact of the cost of cancer treatment: an internet-based survey. J Oncol Pract. 2010;6:69-73.
11. Dillman DA, Smyth JD, Christian LM, et al. Internet, Mail, and Mixed-Mode Surveys: The Tailored Design Method. 3rd ed. Hoboken, NJ: Wiley & Sons; 2009.
12. Lawless RM, Littwin AK, Porter KM, et al. Did bankruptcy reform fail? An empirical study of consumer debtors. Am Bankr L J. 2008;82: 349-405.
13. Regenbogen SE, Veenstra CM, Hawley ST, et al. The personal financial burden of complications after colorectal cancer surgery. Cancer. 2014. [Epub ahead of print].
14. Mujahid MS, Janz NK, Hawley ST, et al. Racial/ethnic differences in job loss for women with breast cancer. J Cancer Surviv. 2011;5: 102-111.
15. Regenbogen SE, Veenstra CM, Hawley ST, et al. The effect of complications on the patient-surgeon relationship after colorectal cancer surgery. Surgery. 2014;155:841-850.
16. Chirikos TN, Russell-Jacobs A, Cantor AB. Indirect economic effects of long-term breast cancer survival. Cancer Pract. 2002;10:248-255.
17. Yabroff KR, Warren JL, Knopf K, et al. Estimating patient time costs associated with colorectal cancer care. Med Care. 2005;43:640-648.
18. Finkelstein EA, Tangka FK, Trogdon JG, et al. The personal financial burden of cancer for the working-aged population. Am J Manag Care. 2009;15:801-806.
19. The National Average Wage Index (AWI): Wage statistics for 2012. Available at: http://www.ssa.gov/cgi-bin/netcomp.cgi?year=2012. Accessed May 2, 2014.
20. Kelley RK, Venook AP. Nonadherence to imatinib during an economic downturn. N Engl J Med. 2010;363:596-598.
21. Kent EE, Forsythe LP, Yabroff KR, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119:3710-3717.
22. Chino F, Peppercorn J, Taylor DH Jr, et al. Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist. 2014;19:414-420.
23. Allen J, Zebrack B, Wittmann D, et al. Expanding the NCCN guidelines for distress management: a model of barriers to the use of coping resources. J Community Support Oncol. 2014;12:271-277.
24. Gupta D, Lis CG, Grutsch JF. Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer. 2007;15:1051-1056.